COPIKTRA is a kinase inhibitor indicated for the treatment of adult patients with:• Relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) after at least two prior therapies.• Relapsed or refractory follicular lymphoma (FL) after at least two prior systemic therapies.